Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000685866 | SCV000813366 | likely benign | Type A2 brachydactyly; Acromesomelic dysplasia 3 | 2024-12-16 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004711142 | SCV005260224 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Genome |
RCV000509388 | SCV000607055 | not provided | Type A2 brachydactyly | no assertion provided | phenotyping only | GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. | |
Prevention |
RCV003409723 | SCV004106349 | uncertain significance | BMPR1B-related disorder | 2024-05-28 | no assertion criteria provided | clinical testing | The BMPR1B c.1112G>A variant is predicted to result in the amino acid substitution p.Arg371Gln. This variant was reported in an individual with pulmonary arterial hypertension (Supplementary Dataset 1 in Wang et al. 2018. PubMed ID: 30578397) and in a patient with cleft lip with/without cleft palate (Marini et al. 2019. PubMed ID: 31063268). This variant is reported in 0.13% of alleles in individuals of South Asian descent in gnomAD, including one homozygous individual. This variant has been interpreted by a single submitter in ClinVar as likely benign (https://preview.ncbi.nlm.nih.gov/clinvar/variation/441001/). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |